Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937) [Phase 2]
Phase 2 trial comparing two dosing strengths of Sublingually Org 5222 (asenapine) to assess safety and equivalence in schizophrenia or schiz…
-
CLINICAL_TRIALS trial_result · 2010-09-27Clinical Trial Update: Efficacy of Bifeprunox in Patients With Schizophrenia [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of bifeprunox in schizophrenia has been terminated; the snippet does not include efficacy r…
-
CLINICAL_TRIALS trial_result · 2010-09-27Clinical Trial Update: Efficacy of Bifeprunox in Patients With Schizophrenia [Phase 3]
A Phase 3 trial evaluating the efficacy of bifeprunox in schizophrenia has been terminated; no efficacy results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2010-09-27Clinical Trial Update: Augmenting Clozapine With Sertindole - SERCLOZ [NA]
The study evaluating adding sertindole to clozapine therapy for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients [Phase 4]
Phase 4 trial evaluating metformin as treatment for antipsychotic-induced amenorrhea in women with schizophrenia has completed. The study ex…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-17Clinical Trial Update: Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose [Phase 3]
A Phase 3 trial comparing quetiapine prolonged-release to oral risperidone in inpatient schizophrenia patients was terminated, with results …
-
FDA approval · 2010-09-03FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for SAPHRIS (asenapine maleate) by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluated atomoxetine for negative symptoms in schizophrenia (and schizoaffective disorder); the study has complete…
-
FDA approval · 2010-08-30FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Risperdal Consta (risperidone) submitted by Janssen Pharmaceuticals, Inc., resulting in a la…
-
FDA approval · 2010-08-30FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-TAB (risperidone) from Janssen Pharmaceuticals, expanding or updating its formulatio…
-
CLINICAL_TRIALS trial_result · 2010-08-25Clinical Trial Update: A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation [Phase 3]
Phase 3 randomized trial evaluating intramuscular ziprasidone for agitation in schizophrenia; trial completed with posted results in 2010.
-
CLINICAL_TRIALS trial_result · 2010-08-25Clinical Trial Update: Entacapone Augmentation for Schizophrenia [NA]
A completed clinical trial evaluating entacapone augmentation for schizophrenia.
-
FDA approval · 2010-08-24FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
The FDA approved a supplemental application for Fanapt (iloperidone) submitted by Vanda Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2010-08-16Clinical Trial Update: Reduction of Cardiovascular Risk in Severe Mental Illness [Phase 4]
Phase 4 clinical trial update exploring reduction of cardiovascular risk in individuals with severe mental illness, including schizophrenia …
-
CLINICAL_TRIALS trial_result · 2010-08-12Clinical Trial Update: A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation for Patients With Refractory Schizophrenia Treated With Clozapine [Phase 3]
Phase 3 double-blind, sham-controlled trial evaluating repetitive transcranial magnetic stimulation for patients with refractory schizophren…
-
CLINICAL_TRIALS trial_result · 2010-08-10Clinical Trial Update: A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 trial evaluating relapse prevention using long-acting injectable risperidone and quetiapine tablets in patients with schizophrenia o…
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness [NA]
Clinical trial update noting the completion and outcome evaluation of the Solutions for Wellness and Team Solutions Program in adults with s…
-
CLINICAL_TRIALS trial_result · 2010-08-06Clinical Trial Update: Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia [Phase 2]
A Phase 2 study of AZD0328 in schizophrenia was terminated, with results posted, evaluating pharmacodynamics, pharmacokinetics, safety and t…
-
FDA approval · 2010-08-06FDA Approved: RISPERIDONE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's generic risperidone (ANDA) for the same indications as the brand-label. The approval covers schizophrenia,…
-
CLINICAL_TRIALS trial_result · 2010-08-06Clinical Trial Update: The Effect of Ketamine on Attentiveness [Phase 1]
Phase 1 trial update examining the effect of ketamine on attentiveness in individuals with schizophrenia; the study has completed.
-
FDA approval · 2010-08-06FDA Approved: RISPERIDONE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s original ANDA for risperidone, providing a generic version of this antipsychotic.
-
CLINICAL_TRIALS trial_result · 2010-08-03Clinical Trial Update: Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism [NA]
A completed clinical trial assessing the effects of the atypical antipsychotics olanzapine and amisulpride on glucose metabolism in individu…
-
CLINICAL_TRIALS trial_result · 2010-07-29Clinical Trial Update: A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia [Phase 3]
Phase 3 trial comparing the metabolic effects of paliperidone ER versus olanzapine in patients with schizophrenia. Results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2010-07-28Clinical Trial Update: The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan
This completed clinical trial from TsaoTun Psychiatric Center in Taiwan assessed how common obesity is among inpatients with schizophrenia. …
-
CLINICAL_TRIALS research · 2010-07-23Clinical Trial Update: The Effectiveness Of Auricular Acupressure On Body Weight Parameters On Patients With Schizophrenia [NA]
This entry reports an update on a clinical trial evaluating whether auricular acupressure affects body weight parameters in patients with sc…